Barclays
IART icon

Barclays’s Integra LifeSciences IART Stock Holding History

Barclays’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-245,100
Closed -$16.8M – 4404
2021
Q3 		$16.8M Buy
+245,100
New +$17.3M 0.01% 959
2021
Q2 		– Sell
-165,400
Closed -$11.4M – 4951
2021
Q1 		$11.4M Buy
+165,400
New +$11.2M 0.01% 1030
2017
Q1 		– Sell
-2,200
Closed -$94K – 6847
2016
Q4 		$94K Buy
+2,200
New +$89.4K ﹤0.01% 4793

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Barclays's IART Position: Q1 2026 in Review

Barclays reduced its Integra LifeSciences (IART) stake by 88% in Q1 2026, selling an estimated $1.01M and leaving 12,796 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #3948.

Barclays first reported a position in IART in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.07M in Q4 2022. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Barclays held 12,796 shares of Integra LifeSciences worth $121K as of Q1 2026.
  • Barclays sold 91,768 Integra LifeSciences shares in Q1 2026, an estimated $1.01M.
  • Integra LifeSciences made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3948 holding.
  • Barclays first reported a position in Integra LifeSciences in Q2 2013 and has held it in 51 quarters since.
  • Barclays's Integra LifeSciences position peaked at $6.07M in Q4 2022.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.